This technology departs from traditional ablation methods that rely on extreme heat or cold to destroy problematic heart tissue. By utilizing targeted electric fields, the new catheter system minimizes the risk of collateral damage to surrounding structures. The integration of advanced 3D cardiac mapping allows physicians to visualize the heart's electrical activity and confirm precise catheter placement before delivering energy.
In section Releases
TCAI Launches Clinical Trial for Pulsed Field Ablation Technology
The Texas Cardiac Arrhythmia Institute at St. David's Medical Center has become the first facility in the United States to trial a next-generation mapping and pulsed field ablation system. Dr. Andrea Natale performed the inaugural procedure, targeting the erratic heart rhythms associated with paroxysmal and persistent atrial fibrillation.
Atrial fibrillation affects millions globally, manifesting as an irregular, rapid heartbeat in the upper chambers of the heart. Early intervention is critical to mitigating the long-term risks of stroke, blood clots, and heart failure. As the global principal investigator for the trial, Dr. Natale noted that pulsed field ablation stands as a significant advancement in electrophysiology, offering a more refined approach to treating sustained arrhythmia. The Texas Cardiac Arrhythmia Institute continues to utilize its six specialized labs to evaluate these emerging tools, aiming to improve clinical outcomes for patients suffering from complex cardiac rhythm disorders.
Comments (0)
No comments yet. Be the first!